Answers are grounded in this paper and cite their sources.
Review highlights benzothiazole derivatives' therapeutic potential and synthesis in medicinal chemistry, suggesting new drug development opportunities.
Benzothiazole (BTZ) is a fused heterocyclic compound of a benzene ring and a thiazole moietythat shows several pharmacological characteristics. Its structural variation has proven advantageous in the development of novel therapeutic medicines, particularly in enhancing efficacy and reducing side effects in various treatments. The high degree of structural diversity of BTZ has set a milestone in the field of medicinal chemistry in providing capping fragments and core scaffolds for targeted drug design and synthesis according to their affinity for particular biological receptors. Over the past decade, researchers have shown their keen interest in the study of BTZ-based compounds in the practice of treating illness with strong therapeutic potency. This review provides a comprehensive idea about their synthesis and their wide range of biological activity, including anti-tubercular, antidiabetic, anticancer, antifungal, anti-Alzheimer, anticonvulsant, antibacterial, antiviral, antimalarial, etc. All of these facts lead to BTZ as a promising moiety for further research and exploration in the medical field. This component holds immense promise for modern drug discovery, which might ultimately lead to the development of novel and superior therapeutic treatments.
No takes yet. Share an insight, caveat, or question.
Talukdar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: